Pays: Arménie
Langue: anglais
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
fluocortolone pivalate, fluocortolone hexanoate, cinchocaine (cinchocaine hydrochloride)
Bayer Healthcare Manufacturing S.r.l.
C05AX03
fluocortolone pivalate, fluocortolone hexanoate, cinchocaine (cinchocaine hydrochloride)
0.918mg/g+ 0,945mg/g+ 5mg/g
ointment rectal
30g aluminium tube
OTC
Registered
2018-07-31
Page 1 of 4 Summary of Product Characteristics Ultraproct, ointment SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ULTRAPROCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One gram of ointment contains: fluocortolone pivalate 0.918 mg fluocortolone caproate 0.945 mg cinchocaine hydrochloride 5.0 mg 3. PHARMACEUTICAL FORM Ointment 4. CLINICAL PARTICULARS _4.1 _ _THERAPEUTIC INDICATIONS _ ■ Hemorrhoids, superficial anal fissures, proctitis. _4.2 _ _POSOLOGY AND METHOD OF ADMINISTRATION _ The anal region should be cleaned thoroughly before using Ultraproct, which is best applied after defecation. There is usually a rapid improvement, but this should not mislead one into stopping treatment too soon. To avoid relapses, Ultraproct should be continued for at least one week, though less frequently (once a day), even when the symptoms have completely disappeared. However, duration of treatment should, as far as possible, not exceed 4 weeks. Generally, Ultraproct ointment is applied twice daily, on the first day for faster symptomatic relief, up to four times. A little ointment (about the size of a pea) is smeared around the anus and in the anal ring with a finger, using the fingertip to overcome the resistance of the sphincter. Before applying within the rectum, the enclosed nozzle should be screwed on to the tube. However, for very inflamed and hence painful lesions, it is advisable initially to apply the ointment internally with the finger. Protruding lumps should be smeared thickly and pressed carefully back with the finger. Pediatric population: not recommended due to lack of clinical data. _4.3 _ _CONTRAINDICATIONS _ Tuberculous or syphilitic processes in the area to be treated; virus diseases (e.g. vaccinia, chickenpox); hypersensitivity to any of components. _4.4 _ _SPECIAL WARNINGS AND PRECAUTIONS FOR USE _ Additional specific therapy is required in fungal infections. Inadvertent contact of the preparation with the eyes should be avoided. Careful handwashing after use is recommended. Page 2 of Lire le document complet